(2024b)
16 In October 2024, Novo Nordisk entered a settlement with Natco Pharma and Mylan (a subsidiary of Viatris) in relation to its product Ozempic
Reducing pressure on your venous system before treatment gives the treatment the best possible environment in which to work
doi: 10.1016/j.molmet.2017.02.002
90 mg: -1.02%, p=0.001), BW (45 mg: -3.51%, p=0.0019
Contact your healthcare provider if you experience: Absent periods (amenorrhea): Missing three or more consecutive menstrual cycles if previously regular, or six or more months if previously irregular Heavy bleeding (menorrhagia): Soaking through a pad or tampon every hour for several consecutive hours, or periods lasting longer than seven days Severe pain: New or worsening menstrual cramping not relieved by over-the-counter medications Intermenstrual bleeding: Bleeding or spotting between periods that persists beyond initial treatment months Pregnancy possibility: Any missed period when pregnancy is possible, as tirzepatide is not recommended during pregnancy Urgent warning signs: Heavy bleeding with dizziness, fainting, rapid heartbeat, or severe weakness requires emergency evaluation Your healthcare provider may recommend specific investigations to evaluate persistent menstrual irregularities
